| ONO-4538 Phase I Study in Patients With Solid Tumor (NCT02261298) | Ono Pharmaceutical Co., Ltd. | 2014-10-01 |
| A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells (NCT02277145) | Jianwu Dai | 2014-10-01 |
| Smoking Cessation for Depression and Anxiety Treatment (NCT02002858) | University of Houston | 2014-10-01 |
| Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS (NCT02212886) | Mapi Pharma Ltd. | 2014-10-01 |
| Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma (NCT02257424) | Abramson Cancer Center at Penn Medicine | 2014-10-01 |
| Phase 1 Trial of Ebola Vaccine in Mali (NCT02267109) | University of Maryland, Baltimore | 2014-10-01 |
| Drug-Drug Interaction Study: ASP2151 and Ciclosporin (NCT02280421) | Maruho Europe Limited | 2014-10-01 |
| First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients (NCT02277717) | Byondis B.V. | 2014-10-01 |
| Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies (NCT02145403) | University of Michigan Rogel Cancer Center | 2014-10-01 |
| Study of Afuresertib Combined With Paclitaxel in Gastric Cancer (NCT02240212) | Novartis Pharmaceuticals | 2014-10-01 |
| Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium (NCT02201238) | GlaxoSmithKline | 2014-10-01 |
| A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis (NCT02282826) | Genzyme, a Sanofi Company | 2014-10-01 |
| Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation (NCT02227641) | University of Erlangen-Nürnberg Medical School | 2014-10-01 |
| A Study of LY2835219 in Healthy Participants (NCT02256267) | Eli Lilly and Company | 2014-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease (NCT02224664) | Pfizer | 2014-10-01 |
| Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma (NCT02248805) | MacroGenics | 2014-10-01 |
| CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas (NCT02259556) | Chinese PLA General Hospital | 2014-10-01 |
| Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers (NCT02291471) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2014-10-01 |
| Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation (NCT02399735) | Third Affiliated Hospital, Sun Yat-Sen University | 2014-10-01 |
| Web-based Physical Activity Program (NCT01218412) | Karnes, Sasha | 2014-10-01 |
| Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer (NCT02120469) | City of Hope Medical Center | 2014-10-01 |
| A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects (NCT02342652) | ASLAN Pharmaceuticals | 2014-10-01 |
| A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants (NCT02271425) | Eli Lilly and Company | 2014-10-01 |
| Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old (NCT02274545) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-10-01 |
| Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis (NCT02649270) | Biotech Pharmaceutical Co., Ltd. | 2014-10-01 |
| Open Label Trial of Nissle 1917 (NCT02276508) | Elizabeth Lucas | 2014-10-01 |
| A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV (NCT02263040) | Mount Sinai Hospital, Canada | 2014-10-01 |
| TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction (NCT02338674) | Fuzhou General Hospital | 2014-10-01 |
| 18-F-Fluoroacetate as PET Imaging Agent (NCT01320787) | M.D. Anderson Cancer Center | 2014-10-01 |
| Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects (NCT02327273) | Bristol-Myers Squibb | 2014-10-01 |
| Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function (NCT02296905) | AbbVie | 2014-10-01 |
| Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours (NCT02215850) | Welichem Biotech Inc. | 2014-10-01 |
| EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs (NCT02061462) | Policlinico Hospital | 2014-10-01 |
| Preoperative Cesarean Section Intravenous Acetaminophen and Postoperative Pain Control (NCT02694653) | University of Tennessee Graduate School of Medicine | 2014-10-01 |
| A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 (NCT02280395) | Pulmatrix Inc. | 2014-10-01 |
| A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds (NCT02284360) | Medical University of Vienna | 2014-10-01 |
| Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study (NCT02572375) | Nexgen Pharma, Inc | 2014-10-01 |
| A Phase I/II Study of Ganetespib in Combination With Doxorubicin (NCT02261805) | Georgetown University | 2014-10-01 |
| Feasibility of the Integrative Medication Self-Management Intervention to Promote Medication Adherence (NCT02706548) | University of Wisconsin, Milwaukee | 2014-10-01 |
| A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers (NCT02272764) | Alkermes, Inc. | 2014-10-01 |
| A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants (NCT02254759) | Hoffmann-La Roche | 2014-10-01 |
| to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage (NCT02271516) | National Atomic Research Institute, Taiwan | 2014-10-01 |
| Home-based Balance Training Using Wii Fit After Stroke: A Feasibility Study (NCT02251470) | Martin-Luther-Universität Halle-Wittenberg | 2014-10-01 |
| Phase I, Dose Escalation Study of Decitabine (NCT02264873) | University of Florida | 2014-10-01 |
| Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer (NCT02278458) | Betta Pharmaceuticals Co., Ltd. | 2014-10-01 |
| The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION) (NCT02273713) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-10-01 |
| Papaya Study ID:20140628 (NCT02051634) | University of Florida | 2014-10-01 |
| Stem Cell Transplantation for Stiff Person Syndrome (SPS) (NCT02282514) | Northwestern University | 2014-10-01 |
| A Pilot Study of Robot-assisted Therapy for Post-stroke Forearm and Wrist Rehabilitation Training (NCT02274675) | Universiti Teknologi Malaysia | 2014-10-01 |
| A Bioequivalence Study Comparing Two Different Tafamidis Formulations (NCT02217813) | Pfizer | 2014-10-01 |
| Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC (NCT02259595) | Otologic Pharmaceutics, Inc. | 2014-10-01 |
| HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer (NCT02063724) | H. Lee Moffitt Cancer Center and Research Institute | 2014-10-01 |
| A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma (NCT02584920) | Shanghai Henlius Biotech | 2014-10-01 |
| Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery (NCT02234297) | Blaze Bioscience Inc. | 2014-10-01 |
| Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers (NCT02269930) | Biogen | 2014-10-01 |
| Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer (NCT02064608) | Cambridge University Hospitals NHS Foundation Trust | 2014-10-01 |
| MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants (NCT02281344) | Medicines for Malaria Venture | 2014-10-01 |
| Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2) (NCT02303860) | Orion Corporation, Orion Pharma | 2014-10-01 |
| Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations (NCT02258321) | Presidio Pharmaceuticals, Inc. | 2014-10-01 |
| A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) (NCT02103283) | Amgen | 2014-10-01 |
| Pharmacokinetic Drug-Drug Interaction Study (NCT03892213) | Drugs for Neglected Diseases | 2014-10-01 |
| Impact of Physical Therapy Program in Mouthbreathing Children After Adenotonsillectomy (NCT02373553) | Federal University of Minas Gerais | 2014-10-01 |
| Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers (NCT02286544) | Karolinska Institutet | 2014-10-01 |
| Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991) (NCT02222441) | Pfizer | 2014-10-01 |
| A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS (NCT02267863) | Aptose Biosciences Inc. | 2014-10-01 |
| Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette (NCT02511704) | Parc de Salut Mar | 2014-10-01 |
| Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome (NCT02297022) | University of Sao Paulo General Hospital | 2014-10-01 |
| PK Study of N91115 in Cystic Fibrosis Patients (NCT02227888) | Nivalis Therapeutics, Inc. | 2014-10-01 |
| Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors (NCT02281409) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
| Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) (NCT02216084) | Baxalta now part of Shire | 2014-09-30 |
| Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults (NCT02496520) | Clinica Universidad de Navarra, Universidad de Navarra | 2014-09-30 |
| The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection (NCT03453801) | Stanford University | 2014-09-30 |
| An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma (NCT02253992) | Bristol-Myers Squibb | 2014-09-29 |
| Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck (NCT02113878) | Dana-Farber Cancer Institute | 2014-09-29 |
| Olaparib and Radiotherapy in Head and Neck Cancer (NCT02229656) | The Netherlands Cancer Institute | 2014-09-24 |
| Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects (NCT02249871) | Novo Nordisk A/S | 2014-09-24 |
| Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia (NCT02153580) | City of Hope Medical Center | 2014-09-24 |
| A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults (NCT02218125) | Crucell Holland BV | 2014-09-23 |
| Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma (NCT02186834) | H. Lee Moffitt Cancer Center and Research Institute | 2014-09-23 |
| Radiolabeled Study of CC-122 in Healthy Subjects (NCT02234999) | Celgene | 2014-09-23 |
| Bioequivalence Study of Co-codamol 15mg/500mg Capsules vs Co-codamol 30mg/500mg Tablets in Healthy Subjects (NCT03280095) | Galen Limited | 2014-09-23 |
| Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers (NCT02228395) | Biogen | 2014-09-22 |
| Study Evaluating Venetoclax in Subjects With Hematological Malignancies (NCT02265731) | AbbVie | 2014-09-22 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder (NCT02211846) | Astellas Pharma Inc | 2014-09-21 |
| A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196 (NCT04914936) | Acerta Pharma BV | 2014-09-21 |
| Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014) (NCT02115347) | Merck Sharp & Dohme LLC | 2014-09-19 |
| Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects (NCT02249910) | Novo Nordisk A/S | 2014-09-18 |
| Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02086604) | Washington University School of Medicine | 2014-09-18 |
| Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck (NCT02201355) | University of Texas Southwestern Medical Center | 2014-09-18 |
| Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy (NCT02286986) | University of Utah | 2014-09-18 |
| Safety and Tolerability of ODM-203 in Subjects With Advanced Solid Tumours (NCT02264418) | Orion Corporation, Orion Pharma | 2014-09-18 |
| Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (NCT02140151) | Southern California Desert Retina Consultants, MC | 2014-09-17 |
| Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010) (NCT02266706) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2014-09-17 |
| A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo (NCT02240875) | University of Oxford | 2014-09-17 |
| Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease (NCT02193191) | Memorial Sloan Kettering Cancer Center | 2014-09-17 |
| A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer (NCT02133742) | Pfizer | 2014-09-16 |
| Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects (NCT02243098) | Novo Nordisk A/S | 2014-09-16 |
| Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers (NCT02404870) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-09-16 |
| Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003) (NCT02174159) | Merck Sharp & Dohme LLC | 2014-09-15 |
| Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma (NCT02189343) | Celgene | 2014-09-15 |